ChemBriefBayer Maintains 2026 Outlook on Improved Q2 Performance
Bayer maintained its 2026 outlook after reporting Q2 earnings that exceeded estimates, driven by improved performance while monitoring external market dynamics.
chemweek · 2026-08-04 17:13 UTC
Bayer maintained its 2026 outlook after reporting Q2 earnings that exceeded estimates, driven by improved performance while monitoring external market dynamics.